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Abstract—Development of miRNA optical biosensors for 
disease diagnosis and monitoring has acquired relevance in 
recent years, due to the clinical importance of miRNA and the 
inherent advantages of optical sensors. Here, we present the 
utilization of a fiber optic sensor based on Lossy Mode 
Resonance (LMR) for the detection of miRNA hsa-miR-223, a 
promising biomarker for the diagnosis of rheumatoid arthritis 
(RA). 
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I. INTRODUCTION
MicroRNAs or miRNAs are small (around 20 nucleotides 
in length) and non-coding RNAs (ribonucleic acids) involved 
in the regulation of gene expression. In recent years, the 
implication of miRNAs in human diseases has been 
thoroughly studied, including autoimmune diseases such as 
rheumatoid arthritis (RA) [1]–[5]. 
Rheumatoid arthritis (RA) is the most common type of 
autoimmune and inflammatory arthritis in adults, affecting 
around 0.5 - 1.0% of the adult population worldwide [6]. In 
rheumatoid arthritis, inflammation is misdirected to attack 
the synovium, which is the membrane that lines the joint. 
The inflammation causes joint pain, stiffness, swelling and 
loss of function, and if it is not stopped or slowed, it can 
permanently damage the affected joints as well as other 
tissues (ligaments, tendons, nerves, blood vessels) [7]. 
Among the miRNAs that play a role in RA, it can be 
found hsa-miR-223-3p, also known as hsa-miR-223 [8]. For 
the rest of this paper, the name ‘miR-223’ will be used, a 
common abbreviation in literature when talking about 
miRNAs (‘hsa’ means the miRNA corresponds to the species 
Homo Sapiens). Low serum levels of miR-223 compared 
with both healthy individuals and established RA patients 
have been associated with early rheumatoid arthritis (ERA) 
[4]. In the case of patients with established RA, increased 
serum miR-223 levels are considered to be connected with 
higher disease activity and disease relapse [4] and a 
correlation has been found in T cells between miR-223 and 
rheumatoid factor (RF), another biomarker for RA [9]. 
Finally, miR-223 is also believed to be a suitable marker for 
studying therapeutic response in RA in case of some drugs 
(DMARDs, anti-TNFα) [4], [10], that is, to determine if the 
treatment is effective or not. Nevertheless, the mechanisms 
that lie under the connection between miR-223 and RA are 
complex and need further research [1]–[5], [10], [11], so here 
the explanation has been synthesized for the sake of 
simplicity. 
On the other hand, fiber optical biosensors are an 
emerging technology that advances towards reliable, highly 
sensitive, reusable, and fully automated platforms for the 
detection of biomarkers [12]. Among them, sensors based on 
Lossy Mode Resonances (LMR) have emerged as a high 
sensitivity refractometric platform [13], [14]; which enables 
their use for biosensing applications [15], [16]. LMR occurs 
when the real part of the thin-film permittivity is positive and 
greater in absolute value than its own imaginary part and the 
real part of the permittivity of the waveguide, so metallic 
oxides and polymers can be employed to generate these 
resonances [17]. 
In this work, it is presented the fabrication of LMR-based 
fiber optic refractometers with SnO2 thin-films on D-shaped 
optical fibers, and their utilization as biosensors for the 
detection of miR-223, a biomarker associated to rheumatoid 
arthritis. 
II. METHODS AND MATERIALS
A. Refractometer manufacture
LMR-based optical fiber refractometers have been
described in previous works [18]. Here, D-shaped single-
mode fiber (SMF) purchased from Phoenix Photonics Ltd., is 
employed as substrate. D-shape fiber consists of a standard 
SMF (SMF-28, Corning®) with a side-polished length of 10 
mm and an attenuation peak of 0.5 dB at 1550 nm in high 
refractive index oil (1.5).  
A thin-film of SnO2 was deposited onto the D-shape 
region to generate the LMR. Regarding the deposition 
procedure, the fiber is placed inside a DC sputtering machine 
(K675XD from Quorum Technologies) at a partial pressure 
of argon of 9x10-2 mbar and an intensity of 90 mA in order to 
achieve 100 nm thick SnO2 coatings. Subsequently, this 
structure is biofunctionalized to allow the detection of miR-
223, as it is described in subsection B (see Fig. 1a, b). 
B. Surface functionalization and bioassay protocol
Once the D-shaped SMF fiber has been coated with a
SnO2 thin-film, there are three different parts that can be 
distinguished in the biosensor manufacture and operation: 1) 
initial biofunctionalization steps, 2) DNA probe (the 
bioreceptor) binding, and 3) miRNA (the biomarker, that is, 
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miR-223) detection. All the binding interactions were 
performed in situ and were continuously monitored. More 
detailed information is given in section III. 
C. Measuring setup 
The experimental setup is detailed in Fig. 1c, consisting 
of a broadband multi-SLED light source (FJORD-X2-1330-
1550 purchased from Pyroistech S.L.), an in-line polarizer, 
and a polarization controller (purchased from Phoenix 
Photonics Ltd.), which enable selecting TE- or TM-polarized 
states of light. An optical spectrum analyzer (MS9740A, 
purchased from Anritsu), is connected to the output to 
monitor the biosensor response in the 1200-1700 nm range.  
III. RESULTS AND DISCUSSION 
1) Initial biofunctionalization steps 
In the first place, the D-shaped region of the SMF fiber is 
immersed in a 0.04% w/v solution of Eudragit® in 99% pure 
alcohol for 1 min and then it is left drying in air for about 15 
min until the solvent has completely evaporated. 
After this step, the D-shaped region is placed inside a 
microfluidic system that is thermo-stabilized by means of 
two Peltier cells. The microfluidic system consists of two 
equal-size pieces, the upper one is made of ULTEM® and 
the lower one is made of stainless steel. A microfluidic 
channel is engraved on both bars with dimensions 1 mm × 1 
mm × 50 mm (volume of 50 μL), with the D-shaped region 
fitting in this channel. A peristaltic pump allows to control 
the flow through the cell. 
Then, once the D-shaped region is correctly placed, a 1-
Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochlo-
ride (EDC) and N-Hydroxysuccinimide (NHS) solution (2 
mM and 5 mM in ultrapure water, 18.1 MΩ/cm) is injected 
and flowed through the cell during 30 min at a flow rate of 
4.4 μL/min.  
2) DNA probe binding 
In order to detect the target miRNA, a first binding of a 
DNA probe to the D-shaped fiber is required. The DNA 
probe is complementary to the target miRNA (miR-223). 
This binding induces a change in the thickness of the coating 
and in the effective refractive index of the outer medium. 
Therefore, an accurate determination of this change can be 
obtained by studying the LMR wavelength shift. 
The DNA probe is immobilized onto the fiber by 
employing biotin as linker but, apart from the 
biofunctionalization operations explained in 1), the following 
steps are required. In all the cases, the flow rate is 4.4 
μL/min. and the buffer that is employed is phosphate 
buffered saline (10 mM PBS, pH 7.4). 
a) Streptavidin (STV, 0.03% w/v) is flowed during 1 h 
b) PBS buffer during 15 min (washing step to recover 
the baseline) 
c) Until this point of the bioassay, the temperature of 
the microfluidic cell has been stabilized at 25ºC. Here, it is 
changed to 32ºC to favor the binding between the DNA 
probe and the miRNA (miR-223), as it has been considered 
an adequate temperature. It will maintain this value for the 
rest of the assay. 
d) PBS buffer during 15 min after the temperature has 
stabilized to its new value (steps d-f are shown in Fig. 2). 
 
Fig. 1. a) Schematic representation of the optical fiber biosensor based on Lossy Mode Resonance. b) Schematic representation of the 
biofunctionalization and sensing principle of the biosensor. c) Experimental setup scheme. 
e) DNA probe (100 μM) during 15 min. This DNA 
probe has been preheated at 50ºC during 10 min to favor its 
unfolding. The DNA probe is complementary to the miRNA 
(miR-223) that must be detected, and its sequence is:        
5’-Biotin- TGG GGT ATT TGA CAA ACT GAC A-3’ (note 
that it has an additional Biotin linker) 
f) PBS buffer during 15 min (washing step). 
Fig. 2 shows the evolution of the central wavelength of 
the LMR during the steps d) - f), once the temperature 
change (step c) has been carried out. It can be observed that 
the LMR wavelength shift associated to the DNA probe 
binding is 4.28 nm (initial change minus the change 
backwards in PBS). 
Step c) is done because, ideally, the working temperature 
must be higher than the melting temperature of both the 
DNA probe and the miRNA (30.9ºC and 23.1ºC respectively, 
in this case) and lower than the melting temperature of the 
hybridization, that is, the binding of the DNA probe and the 
miRNA (70.9ºC in this case).  
This happens because the melting temperature of a 
hairpin, such as the DNA probe or the miRNA, is the 
temperature at which the corresponding hairpin can be 
considered unfolded, that is, a working temperature that is 
higher than this value favors the binding. On the other hand, 
the melting temperature of hybridization is the value at 
which half of the unions among the DNA probe and the 
target miRNAs are considered to be unlinked, so the working 
temperature must be lower than this value. 
3) miRNA (miR-223) detection 
Finally, it must be studied if the biosensor detects the 
miRNA target, that is, the miR-223. The sequence of miR-
223 is: 5’- TGT CAG TTT GTC AAA TAC CCC A-3’. 
Right now, DNA is being employed in these assays instead 
of RNA (thymine, T, instead of uracil, U). In this part of the 
assay, the buffer continues being PBS and the flow rate, 4.4 
μL/min. The following elements are injected and flow 
through the cell (please note that step g) follows step f)): 
g) Bovine serum albumin (BSA, 0.04% w/v) for 10 min 
for surface passivation.. 
h) Target miR-223 (0.02 μM) for 15 min  
i) Target miR-223 (2 μM) for 15 min  
After each of these three steps, a washing step (10 min) is 
done in PBS. All this process can be observed in Fig. 3. All 
miRNAs were preheated at 50ºC for 10 min.  
BSA is employed to fill in the spaces between the DNA 
probes, producing a shift in step g), see Fig. 3. This way, it is 
ensured that the subsequent LMR shift caused by the target 
miRNAs is only due to their binding to the DNA probes. 
As in the case of the DNA probe, the binding of the miR-
223 to the DNA probe is detected through the LMR 
wavelength shift. Nevertheless, as it is shown in Fig. 3, a 
0.02 μM concentration of target miR-223 does not produce 
an appreciable LMR wavelength shift, whereas a 2 μM 
concentration of the target causes a shift of 3.1 nm. After the 
flow of each miR-223 concentration, a PBS washing step is 
done to determine the effective wavelength shift (0 and 3.1 
nm respectively). It is clear the limit of detection of this 
biosensor, with the current configuration, is between 0.02 
and 2 μM, Further research must be carried out in order to 
precisely establish this value and whether it can be improved.  
IV. CONCLUSIONS 
The detection of a miRNA has been performed in this 
work by means of a LMR-based fiber optic biosensor. The 
LMR has been generated by depositing a SnO2 thin-film onto 
a D-shaped optical fiber. The surface is biofunctionalized by 
employing streptavidin and biotin, and the binding of the 
DNA probe and the target miRNA (miR-223) is monitored in 
real time. 
Further research is required to improve the detection 
limit. The optimal working temperature for the binding of the 
DNA probe and the target must be studied in depth. The 
employment of RNA instead of DNA in the case of the target 
and the utilization of other buffers and biofunctionalization 
procedures are also other possibilities that need to be 
considered to lower the detection limit. 
Nevertheless, it has been demonstrated that the use of a 
LMR-based fiber optic biosensor is possible for miRNA 
detection, which opens great possibilities in this field. All 
miRNAs are quite similar in length (around 20 nucleotides) 
and characteristics, so if this biosensor has enabled the 
detection of miR-223, with small changes (working 
temperature, use of the corresponding DNA probe) it should 
be capable of detecting whatever target miRNA. 
 
Fig. 2. Sensogram corresponding to the DNA probe binding (steps d-f).  Fig. 3. Sensogram corresponding to the miR-223 detection. 
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